Clin2
NCT07674862Likely a fitEnrolling by invitation

Safety study of ETD-001 gel in healthy Chinese adults

Safety Issues

This trial tests a new gel called ETD-001 on healthy volunteers to see if it's safe and how the body processes it. If you are a healthy Chinese adult, you might be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
56 people
Ages
16 years to 60 years
Study type
Interventional

Who can take part

  • Be a healthy Chinese man or woman between 18 and 60 years old.
  • Have a body mass index (BMI) between 19 and 26, and weigh at least 50 kg (men) or 45 kg (women).
  • Have no skin issues like cuts, rashes, tattoos, or too much hair where the gel will be applied.
  • Not be pregnant or breastfeeding, and agree to use effective birth control from screening until 6 months after the last dose.
  • Not have taken any prescription or over-the-counter drugs, vitamins, or herbal supplements within 14 days before the first dose.
  • Not smoke more than 5 cigarettes a day or drink more than 14 units of alcohol per week.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07684196Recruiting· Phase 1
First test of ENC0653 ointment in healthy adults

This study tests a new ointment called ENC0653 in healthy adults to see if it is safe and how it works in the body. It is the first time this ointment is being tested in people, so if you are healthy and your skin is clear, you may be able to help.

Shanghai, Xuhui District
NCT07473570Recruiting· Phase 1
Safety study of GS3-007a in healthy adults

This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.

Shanghai, Shanghai Municipality
NCT07098091Enrolling by invitation· Phase 1
Testing the safety of YD0293 in healthy adults

This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Suzhou, Jiangsu
NCT07469085Recruiting· Phase 1
Safety study of SV003 in healthy volunteers

This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.

Shanghai
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT06867393Recruiting· Phase 1
Safety study of HL-003 in healthy volunteers

This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.

Suzhou, Jiangsu

Hear when a new Safety Issues trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.